معرفی
Deborah Gill is a Professor of Gene Medicine and Head of the Nuffield Division of Clinical Laboratory Sciences at the University of Oxford's Radcliffe Department of Medicine. She is based at the John Radcliffe Hospital, where she leads the Gene Medicine Research Group. Her work focuses on gene therapy applications for lung diseases, particularly Cystic Fibrosis (CF) and rare conditions like Surfactant Protein Deficiency.
Education: PhD in Molecular Microbiology (University of Warwick) and BSc (Hons). Her research spans ABC protein studies, viral/non-viral vectors for gene delivery, and clinical translation of therapies. She co-founded the UK Respiratory Gene Therapy Consortium.
Research emphasizes translational medicine, including phase 2b CF trials and preclinical studies on surfactant protein deficiencies. Her lab develops novel delivery systems to enhance gene expression efficacy and reduce inflammation.
Awards: While specific honors are not listed, her contributions to CF therapy and lung gene therapy have significant clinical impact. Her team's work has advanced viral vector engineering and clinical trial methodologies.
Advising/Grants: Supervises projects on lentiviral stability, pulmonary fibrosis, and SARS-CoV-2 immune responses. Collaborates with interdisciplinary teams in Oxford and the UK Consortium. Active in preclinical and clinical-stage research pipelines.
Labs/Teams: Leads the Gill and Hyde Group (Gene Medicine) and contributes to the UK Respiratory Gene Therapy Consortium, fostering cross-institutional collaboration in lung disease research.
